Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • THE ICET-A SURVEY ON CURRENT CRITERIA USED BY CLINICIANS FOR THE ASSESSMENT OF CENTRAL ADRENAL INSUFFICIENCY IN THALASSEMIA: ANALYSIS OF RESULTS AND RECOMMENDATIONS

    Vincenzo De Sanctis
    e2016034
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.034
    3977
    PDF: 1021
    HTML: 1758
  • COMPREHENSIVE REVIEW OF GENETIC AND EPIGENETICS REGULATION OF FETAL HEMOGLOBIN IN β-HEMOGLOBINOPATHIES: FROM MOLECULAR MECHANISMS TO CLINICAL APPLICATIONS HbF Genetics in Anemia

    Yousef Saeed Mohammad Abu Za’ror, Joseph Bagi Suleiman, Fatima Azzahra Delmani, Jehad Farouq Alhmoud, Amer Mohammad Ayasreh, Sarah Ihsan Al-wendawi, Maryam Azlan
    e2026046
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.046
    1087
    PDF: 784
    HTML: 171
  • POST-TRANSPLANT RELAPSE IN ACUTE LEUKEMIA: COMPARATIVE VALUE OF MRD AND CHIMERISM.

    Sinem Başak Tan Öksüz, Güldane Cengiz Seval, Klara Dalva, Selami Koçak Toprak
    e2026028
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.028
    1301
    PDF: 686
    Suppl. Files: 161
    HTML: 556
  • The diagnostic approach to central adrenocortical insufficiency (CAI) in thalassemia

    Vincenzo De Sanctis, Heba Elsedfy, Ashraf T Soliman
    e2016026
    2016-05-01
    https://doi.org/10.4084/mjhid.2016.026
    3268
    PDF: 1087
    HTML: 2833
  • INFECTIONS IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Bianca Maria Ricerca, Arturo Di Girolamo, Deborah Rund
    e2009028
    2009-12-28
    1506
    PDF: 749
    HTML: 4480
  • CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2022069
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.069
    3540
    PDF: 1046
    HTML: 4999
  • PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

    Francesco Rodeghiero
    e2021032
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.032
    3054
    PDF: 1057
    HTML: 674
  • DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE

    Hui Liu, Lorraine Gemmell, Rui Lin, Fengrong Zuo, Henry H. Balfour, Jr., Jennifer C. Woo, Gregory M. Hayes
    e2020016
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.016
    2109
    PDF: 1187
    HTML: 459
  • PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries

    Dr, Moleti, Anna Maria Testi
    e2024078
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.078
    1459
    PDF: 1004
    HTML: 373
  • ROLE OF BIOMARKERS AS PREDICTORS OF INFECTION AND DEATH IN NEUTROPENIC FEBRILE PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.

    Karim Massaro, Silvia F Costa
    e2015059
    2015-10-15
    https://doi.org/10.4084/mjhid.2015.059
    2332
    PDF: 1100
    HTML: 1828
  • IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

    Benedetto Maurizio Celesia, Dr., Andrea Marino, Dr., Rosa Fontana del Vecchio, Dr., Roberto Bruno, Dr., Filippo Palermo, Professor, Maria Gussio, Dr., Giuseppe Nunnari, Professor, Bruno Cacopardo, Professor
    e2019063
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.063
    1631
    PDF: 833
    HTML: 275
  • ASSOCIATION OF BASELINE PLATELET COUNT WITH COMPLETE REMISSION, SEVERE BLEEDING, AND 24-MONTH OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: A SINGLE-CENTER RETROSPECTIVE COHORT STUDY

    Tao Zhou, Zengfeng Ni, Wenjing Fan, Jing Xu, Jing Qin, Kaiyue Wang, Rui Wang, Yaping Li
    e2026071
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.071
    196
    PDF: 162
    Suppl. Files: 33
    Html: 37
    Html Suppl. Files: 26
  • BASELINE THROMBIN GENERATION TEST DOES NOT PREDICT THROMBOTIC EVENTS IN ACUTE LEUKEMIA: A MONOCENTRIC PROSPECTIVE STUDY

    Mario Biglietto, Rosaria Mormile, Maria Laura Bisegna, Alessandro Laganà, Anna Laura Faccini, Andrea Papa, Erminia Baldacci, Cristina Santoro, Maria Stefania De Propris, Antonio Chistolini
    e2025076
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.076
    569
    PDF: 287
    Html: 118
  • Simultaneous presentation of Hemophagocytic Lymphohistiocytosis and Classical Hodgkin's Lymphoma in a patient with underlying germline homozygous STXBP2 Mutation.

    Dr Shilpa Gupta, Dr Amrita Rajendran , Dr Akanksha Chichra , Dr Ayubali Qureshi
    e2026043
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.043
    414
    PDF: 266
    HTML: 98
  • ACQUIRED HYPOGONADOTROPIC HYPOGONADISM (AHH) IN THALASSAEMIA MAJOR PATIENTS: AN UNDERDIAGNOSED CONDITION?

    Vincenzo De Sanctis
    e2016001
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.001
    5739
    PDF: 1399
    HTML: 3703
  • Lung Clear “Sugar” Cell Tumor and Jak V617f Positive Essential Thrombocythemia: A simple Co?nc?dence?

    Volkan Yazak, Gokhan Sargin, Irfan Yavasoglu, Gurhan Kadikoylu, Canten Tataroglu, Gokay Bozkurt, Zahit Bolaman
    e2013021
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.021
    1431
    PDF: 801
    HTML: 2678
  • AN INEXPENSIVE CLINICAL-LABORATORY NOMOGRAM TO PREDICT POST-TREATMENT LUNG DESTRUCTION IN PULMONARY TUBERCULOSIS

    Min Xu, Jiahui He, Jianju Feng
    e2025075
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.075
    807
    PDF: 404
    Suppl. Files: 106
    Html: 90
  • DAYS ALIVE OUTSIDE HOSPITAL AND RE-ADMISSIONS IN PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTS FROM IDENTICAL SIBLINGS, UNRELATED DONORS OR HAPLOIDENTICAL DONORS “.

    Federica Sorà, patrizia chiusolo, luca laurenti, idanna innocenti, francesco autore, sabrina giammarco, elisabetta metafuni, eleonora alma, alessia di giovanni, simona sica, andrea bacigalupo
    e2020055
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.055
    1407
    PDF: 766
    HTML: 366
  • OPTIMIZATION OF THE CLINICAL JOURNEY OF UNFIT PATIENTS WITH NEWLY DIAGNOSED IDH1M ACUTE MYELOID LEUKEMIA

    Adriano Venditti, Marta Riva, Livio Pagano, Giovanni Marconi, Nicola Fracchiolla, Romano Danesi, Antonio Curti, Anna Candoni, Erika Borlenghi, Maria Teresa Voso
    e2026086
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.086
    143
    PDF: 85
    Html: 27
  • GOOD OUTCOME FOR VERY HIGH RISK ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA CARRYING GENETIC ABNORMALITIES t(4;11)(q21;q23) or t(9;22)(q34;q11), IF PROMPTLY SUBMITTED TO ALLOGENEIC TRANSPLANTATION, AFTER OBTAINING A GOOD MOLECULAR REMISSION.

    Matteo Parma, Clara Vigano', Monica Fumagalli, Federica Colnaghi, Arianna Colombo, Federica Mottadelli, Vincenzo Rossi, Elena Elli, Elisabetta Terruzzi, Angelo Belotti, Giovanni Cazzaniga, Enrico Maria Pogliani, Pietro Pioltelli
    e2015041
    2015-05-26
    https://doi.org/10.4084/mjhid.2015.041
    2348
    PDF: 1120
    HTML: 1252
  • IMPORTANCE OF SOURCE CONTROL IN THE SUBGROUP OF INTRA-ABDOMINAL INFECTIONS FOR SEPTIC SHOCK PATIENTS: ANALYSIS OF 390 CASES

    Uğur Önal, Deniz Akyol, Olcay Buse Kenanoğlu, Merve Mert, Dilşah Başkol, Seichan Chousein Memetali, Gamze Şanlıdağ, Cansu Bulut, Arda Kaya, Ayşe Uyan Önal, Nazlıhan Yalçın, Günel Guliyeva, Şükrü Dirik, Oğuzhan Acet, Damla Akdağ, Melike Demir, Osman Bozbıyık, Berk Göktepe, Tufan Gümüş, İlkin Çankayalı, Kubilay Demirağ, Mehmet Uyar, Hilal Sipahi, Hüseyin Aytaç Erdem, Meltem Işıkgöz Taşbakan, Bilgin Arda, Şöhret Aydemir, Sercan Ulusoy, Oğuz Reşat Sipahi
    e2024051
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.051
    1267
    PDF: 1247
    HTML: 270
  • Stroke in a patient with tuberculous meningitis and HIV infection

    Maria Bruna Pasticci, Maurizio Paciaroni, Piero Floridi, Enisia Cecchini, Franco Baldelli
    e2013017
    2013-02-18
    https://doi.org/10.4084/mjhid.2013.017
    1867
    PDF: 907
    HTML: 1905
    figure 1: 218
  • TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS.

    Charicleia Kelaidi, Lionel Ades, Pierre Fenaux
    e2011038
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.038
    3160
    PDF: 1062
    HTML: 2466
  • MOLECULAR MARKERS IN AML: PROGNOSTIC IMPLICATIONS AND IMPACT ON TREATMENT DECISION-MAKING

    Patrizia Chiusolo, Roberto Maggi, Angela Alessi, Simona Sica
    e2026087
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.087
    129
    PDF: 83
    Html: 50
  • ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication

    Maria Chiara Tisi, Giuseppe Ausoni, Maria Gabriella Vita, Tommaso Tartaglione, Mario Balducci, Luca Laurenti, Patrizia Chiusolo, Stefan Hohaus, Simona Sica
    e2015025
    2015-02-17
    https://doi.org/10.4084/mjhid.2015.025
    2562
    PDF: 1106
    HTML: 1684
    Fig 1: 288
    Tab I: 271
    Cover Letter: 287
  • ACUTE LEUKEMIA AND LATENT TUBERCULOSIS INFECTION IN ITALY: QUANTIFERON-TB TEST SCREENING IN A LOW TUBERCULOSIS INCIDENCE COUNTRY

    Andrea Nunzi, Luigi Della Valle, Elisa Linnea Lindfors Rossi, Giorgia Ranucci, Flavia Mallegni, Federico Moretti, Elisa Meddi, Luca Guarnera, Ilaria Tiravanti, Kristian Taka, Elisa Buzzatti, Fabiana Esposito, Roberto Secchi, Francesca Di Giuliano, Flavia Chirico, Raffaele Palmieri, Luca Maurillo, Francesco Buccisano, Carmelo Gurnari, Giovangiacinto Paterno, Adriano Venditti, Maria Ilaria Del Principe
    e2024054
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.054
    1181
    PDF: 972
    HTML: 270
  • PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.

    Dilip Kumar Patel, Manoj Kumar Mohapatra, Ancil George Thomas, Siris Patel, Prasanta Purohit
    e2014018
    2014-02-16
    https://doi.org/10.4084/mjhid.2014.018
    2212
    PDF: 1138
    HTML: 15751
    COVER LETTER: 275
  • SYSTEMIC MASTOCYTOSIS: MOLECULAR LANDSCAPE AND IMPLICATIONS FOR TREATMENT

    Cecilia Monaldi, Sara De Santis, Manuela Mancini, Samantha Bruno, Michele Cavo, Simona Soverini
    e2021046
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.046
    1600
    PDF: 824
    HTML: 510
  • DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA

    Juan Eduardo Megias-Vericat, David Martínez-Cuadrón, Joaquin Martínez López, Juan Miguel Bergua, Mar Tormo, Josefina Serrano, Ataulfo González, Jaime Pérez de Oteyza, Susana Vives, Belen Vidriales, Pilar Herrera, Juan Antonio Vera, Aurelio López Martínez, Adolfo De la Fuente, María Lourdes Amador, José Ángel Hernández-Rivas, María Ángeles Fernández, Carlos Javier Cerveró, Daniel Morillo, Pilar Hernández Campo, Julián Gorrochategui, Daniel Primo, José Luis Rojas, Margarita Guenova, Joan Ballesteros, Miguel Ángel Sanz, Pau Montesinos
    e2019016
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.016
    2203
    PDF: 1230
    HTML: 338
  • A PROSPECTIVE STUDY OF BRUCELLOSIS IN CHILDREN: RELATIVE FREQUENCY OF PANCYTOPENIA

    Mohamed El Koumi, Mona Afify, Salha Al-Zahrani
    e2013011
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.011
    2387
    PDF: 934
    HTML: 4055
  • HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases

    Donato Rigante, Helena Pelanda, Eleonora Rulli, Murad Sultanov, Susanna Adornato
    e2026025
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.025
    1314
    PDF: 964
    HTML: 314
  • Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia

    Alhossain A. Khalafallah, Zafreen Rahman, Kath Ogden, Terry Hannan
    e2012003
    2012-01-18
    https://doi.org/10.4084/mjhid.2012.003
    1664
    PDF: 938
    HTML: 1135
    Untitled: 231
  • EBV CHRONIC INFECTIONS

    Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti
    e2010022
    2010-08-09
    https://doi.org/10.4084/mjhid.2010.022
    3763
    PDF: 1748
    HTML: 8018
  • EFFECT OF NEBULIZED COLISTIN ON THE VENTILATOR CIRCUIT: A PROSPECTIVE PILOT CASE-CONTROL STUDY FROM A SINGLE CANCER CENTER

    Iyad M Ghonimat, Lama H Nazer, Flsteen Aqel, Mohammad K Mohammad, Feras I Hawari, Jennifer Le
    e2015032
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.032
    1875
    PDF: 897
    HTML: 1868
  • ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

    Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante
    e2022008
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.008
    2755
    PDF: 1309
    HTML: 1129
  • ACQUIRED REFRACTORY IRON DEFICIENCY

    Margherita Migone De Amicis, Alessandro Rimondi, Luca Elli, Irene Motta
    e2021028
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.028
    3882
    PDF: 1322
    HTML: 1670
  • PREVALENCE OF HEPATITIS C AMONG EGYPTIAN CHILDREN WITH SICKLE CELL DISEASE AND THE ROLE OF IL28B GENE POLYMORPHISMS IN SPONTANEOUS VIRAL CLEARANCE

    Somaia Mohammed Mousa, Mona Kamal El-Ghamrawy, Heba Gouda, Mervat Khorshied, Dina Ahmed, Hala Shiba
    e2016007
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.007
    3961
    PDF: 904
    HTML: 2546
  • END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRANSFUSION-DEPENDENT β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATIONS Challenges in Supportive Care, Equity, and Compassion at End of Life

    Dr. Sophia Delicou, Dr Katerina Xydaki, Dr Maria Moraki, Dr Theodoros Aforozis
    e2026015
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.015
    1329
    PDF: 920
    Html: 220
  • EFFECT OF CIS ACTING POTENTIAL REGULATORS IN THE ß GLOBIN GENE CLUSTER ON THE PRODUCTION OF HBF IN THALASSEMIA PATIENTS

    Anita Nadkarni
    e2013012
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.012
    1422
    PDF: 676
    HTML: 3435
  • THERAPEUTIC OPTIONS FOR PATIENTS WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY

    Elihu Estey
    e2013050
    2013-07-12
    https://doi.org/10.4084/mjhid.2013.050
    2338
    PDF: 852
    HTML: 1654
  • THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies

    Emine Atli, Rasime Kalkan, Cisem Mail, Damla Eker, Ufuk Demirci, Selma Demir, Sinem Yalcintepe, Hakki Onur Kirkizlar, Engin Atli, Hakan Gurkan, Ahmet Muzaffer Demir
    e2021013
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.013
    2533
    PDF: 681
    HTML: 393
  • ACUTE PROMYELOCYTIC LEUKEMIA: AN EXPERIENCE ON 95 GREEK PATIENTS TREATED IN THE ALL-TRANS-RETINOIC ACID ERA

    Maria Pagoni, Maria Garofalaki, Fotios Panitsas, Kalliopi Manola, Katerina Psarra, Panagiotis Economopoulos
    e2011053
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.053
    3036
    PDF: 997
    HTML: 3644
  • DOES INSULIN LIKE GROWTH FACTOR-1 (IGF-1) DEFICIENCY HAVE A “PROTECTIVE” ROLE IN THE DEVELOPMENT OF DIABETIC RETINOPATHY IN THALASSEMIA MAJOR PATIENTS?

    Vincenzo De Sanctis
    e2015038
    2015-05-20
    https://doi.org/10.4084/mjhid.2015.038
    2140
    PDF: 1027
    HTML: 5199
  • MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY

    Francesco Lococo, Roberto Latagliata, Massimo Breccia
    e2013045
    2013-06-08
    https://doi.org/10.4084/mjhid.2013.045
    2994
    PDF: 1292
    HTML: 3340
  • HOW I APPROACH HEMATOLOGIC ABNORMALITIES IN HOSPITALIZED PATIENTS WITH INFECTIOUS DISEASES

    Michele Bibas
    e2026085
    2026-10-31
    https://doi.org/10.4084/MJHID.2026.085
    124
    PDF: 113
    Html: 149
  • DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura

    Yi Liu, Fan Lu, Binbin Ji, Wei Song, Hui Shen, Yingjie Xu, bining Yang
    e2026019
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.019
    992
    PDF: 846
    HTML: 258
  • COMPARISON OF THE POWER OF PROCALCITONIN AND C-REACTIVE PROTEIN TO DISCRIMINATE BETWEEN DIFFERENT AETIOLOGIES OF FEVER IN PROLONGED PROFOUND NEUTROPENIA: A SINGLE-CENTRE PROSPECTIVE OBSERVATIONAL STUDY.

    Anke Verlinden, Veronique De Vroey, Herman Goossens, Ella Roelant, Ann Van de Velde, Zwi Berneman, Wilfried Schroyens, Alain Gadisseur
    e2019023
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.023
    6943
    PDF: 1168
    HTML: 536
  • Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

    Monica Carpenedo, Dr, Dr, Dr
    e2023021
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.021
    1380
    PDF: 1248
    HTML: 755
  • Challenging management of severe differentiation syndrome in pediatric acute promyelocytic leukemia treated with ATRA/ATO

    Alessandro Molinaro, Daniela Zanta, Maria Luisa Moleti, Fiorina Giona, Valentino Conter, Carmelo Rizzari, Andrea Biondi, Anna Maria Testi
    e2022027
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.027
    2485
    HTML: 306
    PDF: 715
  • REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy

    Ulrike Bacher, Simon Brechbühl, Barbara Jeker, Thomas Pabst
    e2021012
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.012
    1795
    PDF: 834
    HTML: 1526
101 - 150 of 500 items << < 1 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.